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Summary
 
We molecularly cloned a new Grb2 family member, named Grf40, containing the common
SH3-SH2-SH3 motif. Expression of Grf40 is predominant in hematopoietic cells, particularly
T cells. Grf40 binds to the SH2 domain–containing leukocyte protein of 76 kD (SLP-76) via
its SH3 domain more tightly than Grb2. Incidentally, Grf40 binds to linker for activation of
T cells (LAT) possibly via its SH2 domain. Overexpression of wild-type Grf40 in Jurkat cells in-
duced a significant increase of SLP-76–dependent interleukin (IL)-2 promoter and nuclear fac-
tor of activated T cell (NF-AT) activation upon T cell receptor (TCR) stimulation, whereas the
COOH-terminal SH3-deleted Grf40 mutant lacked any recognizable increase in IL-2 promoter
activity. Furthermore, the SH2-deleted Grf40 mutant led to a marked inhibition of these regula-
tory activities, the effect of which is apparently stronger than that of the SH2-deleted Grb2 mu-
tant. Our data suggest that Grf40 is an adaptor molecule involved in TCR-mediated signaling
through a more efficient interaction than Grb2 with SLP-76 and LAT.
Key words: Grb2 family • SLP-76 • T cell receptor signaling • nuclear factor of activated T cells
 
S
 
timulation of the TCR initiates activation of cytoplas-
mic protein tyrosine kinases (PTKs)
 
1
 
 that trigger down-
stream signaling pathways including calcium- and Ras-
dependent events, which ultimately converge upon the
nucleus to stimulate the transcription of genes required for
proliferation and effector functions of T cells (1–4). Phos-
pholipase C
 
g
 
1, recruited to the plasma membrane after PTK
activation, is thought to introduce the calcium-dependent
pathway into the TCR-mediated signaling events (5, 6).
On the other hand, the pathway for Ras activation after
PTK activation in T cells is still controversial. Grb2, an
adaptor protein containing an SH3-SH2-SH3 motif, forms
a complex with Sos, a guanine nucleotide exchange factor,
 
via its NH
 
2
 
-terminal SH3 domain after TCR ligation (7–9).
Hence, the Grb2–Sos complex is thought to contribute to
Ras activation in T cells, although there has been no em-
pirical evidence for this notion.
The COOH-terminal SH3 domain of Grb2 has been
shown to bind to the SH2 domain–containing leukocyte
protein of 76 kD (SLP-76), a hematopoietic cell–specific
adaptor protein, which is tyrosine phosphorylated rapidly
after TCR stimulation (10–12). Mice targeted for SLP-76
gene engendered defects of double-positive T cells in the
thymus and of peripheral T cells as a consequence of im-
paired pre-TCR signaling (13). Furthermore, Jurkat subline
J14 cells lacking expression of SLP-76 exhibited defects of
both the calcium- and Ras-dependent pathways in TCR-
mediated signaling. The defect of the calcium-dependent
pathway in this system is ascribed to the fact that tyrosine
phosphorylation and activation of phospholipase C
 
g
 
1 are
significantly suppressed in J14 cells (14). Although the pre-
cise function of SLP-76 in Ras activation is still obscure, it is
of interest that deletion of the Grb2-binding site of SLP-76
eliminates the ability of SLP-76 to increase IL-2 promoter
activity upon stimulation with the TCR (15, 16). In addi-
tion, SLP-76 also binds to Vav, a member of the guanine
nucleotide exchange factor family, and cotransfection with
SLP-76 and Vav into Jurkat cells induced a synergistic in-
crease of nuclear factor of activated T cell (NF-AT) activa-
tion upon TCR stimulation (17). These observations suggest
that SLP-76 is an indispensable mediator of TCR signaling.
On the other hand, the SH2 domain of Grb2 has been
 
1
 
Abbreviations used in this paper:
 
 LAT, linker for activation of T cells; NF-AT,
nuclear factor of activated T cells; PTK, protein tyrosine kinase; SLP-76,
SH2 domain–containing leukocyte protein of 76 kD; STAM, signal trans-
ducing adaptor molecule. 
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shown to bind to linker for activation of T cells (LAT), a
ZAP-70 tyrosine kinase substrate, upon TCR stimulation,
and the LAT mutant, lacking an interaction site for the
SH2 domain, has a dominant-negative effect on TCR-stim-
ulated signaling (18). Hence Grb2, an adaptor protein, has
been considered to be implicated in TCR-mediated signal-
ing. We here provide evidence that a new Grb2 family mem-
ber, named Grf40, is involved in TCR-mediated signaling
through its more efficient interaction than Grb2 with SLP-76
and LAT.
 
Materials and Methods
 
Cloning of the cDNA.
 
Grf40 cDNA fragments were isolated
by a yeast two-hybrid screen of a human PHA-PBL cDNA li-
brary (Clontech). The bait plasmid was constructed by insertion
of a cDNA fragment encoding the full-length human AMSH
protein (our unpublished protocol) in pAS2-1 (Clontech). The
bait plasmid was transformed into the yeast strain CG1945 (Clon-
tech), followed by transformation with the human PHA-PBL
cDNA library. The transformed strains were selected on dropout
plates (Trp
 
2
 
, Leu
 
2
 
, His
 
2
 
) with 5 mM 3-aminotriazole. Positive
colonies were subsequently tested for the expression of lacZ. One
clone was determined to contain a homologous sequence to
Grb2 (7). To obtain the full-length cDNA, the 800-bp fragment
of the above clone was used as a probe for screening a 
 
l
 
gt11
oligo(dT)-primed cDNA library of PHA-PBL. The sequences of
10 clones were identical, and two of them contained an open
reading frame coding for 330 amino acids. This sequence con-
tains an in-frame stop codon at 114 bp upstream of the first me-
thionine codon, and the sequence around the first methionine
(nucleotides 193–195) matches the favorable Kozak consensus se-
quence. A full-length cDNA encoding Grf40 was thus isolated.
 
Plasmid Construction.
 
Grf40 cDNA was generated by PCR
using the above full-length cDNA clone as a template and sub-
cloned into Myc-Tag-pcDNA3.1(
 
1
 
) to generate the plasmid
sequence (EQKLISEEDL). pMycGrf40-dSH3N, pMycGrf40-dSH2,
pMycGrf40-dSH3C, and pMycGrf40-dSH3NC are Myc-tagged
Grf40 mutants deleted of the SH3 domain of the NH
 
2
 
 terminus
(amino acid position Met
 
1
 
–Pro
 
56
 
), deleted of the SH2 domain
(amino acid position Lys
 
57
 
–Thr
 
149
 
), of the SH3 domain of the
COOH terminus (amino acid position Ala
 
278
 
–Arg
 
330
 
), and of the
SH3 domains of the NH
 
2
 
 and COOH termini (amino acid posi-
tions Met
 
1
 
–Pro
 
56
 
 and Ala
 
278
 
–Arg
 
330
 
), respectively. pMycGrb2 and
pMycGrb2-dSH2 are expression plasmids for the Myc-tagged
wild-type Grb2 and Grb2 mutant deleted of the SH2 domain
(amino acid position Trp
 
60
 
–Glu
 
152
 
), respectively. SLP-76 cDNA
was generated by PCR and subcloned into pFLAG-CMV-2 (East-
man Kodak Co.) to generate the plasmid pFlagSLP, possessing an
NH
 
2
 
-terminal Flag epitope tag (DYKDDDDK). pFlagSLP-157-
533, pFlagSLP-217-533, pFlagSLP-241-533, and pFlagSLP-281-
533 are expression plasmids for Flag-tagged SLP-76 mutants deleted
of amino acid positions Met
 
1
 
–Leu
 
156
 
, Met
 
1
 
–His
 
216
 
, Met
 
1
 
–Lys
 
240
 
,
and Met
 
1
 
–Pro
 
280
 
, respectively. pCX-SLP76 is an expression plas-
mid for the wild-type SLP-76 cloned into the pCXN2 vector
(19). Luciferase reporter constructs were as follows: pNFATLuc
was constructed by insertion of three tandem copies of the NF-AT
binding region (
 
2
 
286 to 
 
2
 
249 of human IL-2) linked to the hu-
man IL-2 promoter (
 
2
 
64 to 
 
1
 
47) into the pGL3-basic vector
(Promega) (20); pIL2Luc was constructed by insertion of the hu-
man IL-2 promoter (
 
2
 
541 to 
 
1
 
57) into the pGL3-basic vector
(21). pENL is a 
 
b
 
-galactosidase expression plasmid (22). All con-
 
structs were sequenced for verification with a DNA sequencer
(model 377; Applied Biosystems, Inc.).
 
Cell Culture.
 
Cell lines used were human T cell lines, Jurkat
and MOLT-4; human B cell lines, Daudi, Raji, and Ramos; a
human monocytic cell line, THP-1; a human eosinophilic cell
line, Eol-3; a human GM-CSF–responsive cell line, TF-1; a hu-
man lung fibroblastic cell line, WI-26; a human epithelial cell line,
HeLa; and an SV40-transformed monkey kidney cell line, COS7.
TF-1 was maintained in RPMI 1640 medium supplemented
with 10% FCS and recombinant GM-CSF. WI-26 and COS7
were maintained in DME supplemented with 5% FCS. Other
cell lines were maintained in RPMI 1640 supplemented with
10% FCS.
 
Abs.
 
The following Abs were used in this study: anti-CD3
 
e
 
mAb OKT3 (American Type Culture Collection); antiphospho-
tyrosine mAb 4G10, anti-Myc polyclonal Ab and anti-LAT Ab
(Upstate Biotechnology); antiphosphotyrosine mAb PY-20 (ICN
Biomedicals); anti-Myc mAb (9E10) and anti-Grb2 Ab (sc-255)
(Santa Cruz Biotechnology); anti-Flag mAb (M2; Eastman Kodak
Co.). Anti-Grf40 rabbit antiserum was prepared by immunization
with a peptide (Val
 
174
 
–Pro
 
194
 
) of human Grf40. Anti–SLP-76 rab-
bit antiserum was prepared by immunization with a peptide
(Gly
 
302
 
–Glu
 
321
 
) of human SLP-76. Anti-B19 human parvovirus
mAb (Par1) was used as a control mAb.
 
Immunoprecipitation and Immunoblotting.
 
Immunoprecipitation
and immunoblotting were carried out as described previously
(23). In brief, cells were lysed with a cell extraction buffer (1%
NP-40, 20 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1 mM
EDTA, 1 mM Na
 
3
 
VO
 
4
 
, 2 mM PMSF, and 20 
 
m
 
g/ml aprotinin),
and immunoprecipitated with the indicated Abs or antisera. The
immunoprecipitates were separated by SDS-PAGE and then
transferred to polyvinylidene difluoride filters (Millipore). After
incubation in PBS containing 2% BSA and 0.1% Tween 20, the
filters were probed with the indicated Abs and visualized using
the ECL detection system (Amersham Pharmacia Biotech).
 
Northern Blotting.
 
Northern blot analyses were performed as
described previously (24). In brief, a Multiple Tissue Northern
blot containing poly(A)
 
1
 
 RNA preparations derived from various
human tissues was purchased (Clontech). They were probed with
radiolabeled cDNA fragments of Grf40 and 
 
b
 
-actin. Signals were
analyzed with a Bio-Image Analyzer, BAS 1500 (Fuji Film and
Photo, Inc.).
 
Transient Transfections and Luciferase Assay.
 
COS7 cells were
electroporated with the indicated plasmids in OPTI-MEM I
(GIBCO BRL) at a density of 6 
 
3
 
 10
 
6
 
 cells/700 
 
m
 
l/cuvette with
a gene pulser (Bio-Rad Laboratories) set at 1,000 V and 200 
 
m
 
F,
and then subjected to a Western blot assay 48 h after the trans-
fection. For luciferase assays, Jurkat cells were electroporated with
2.5 
 
m
 
g of pENL and the indicated dose of pIL2Luc or pNFATLuc,
along with expression plasmids for SLP-76, and Grf40 or Grb2 in
OPTI-MEM I at a density of 5 
 
3
 
 10
 
6
 
 cells/400 
 
m
 
l at 200 V and
950 
 
m
 
F. The cells were cultured at 37
 
8
 
C for 24 h, and then stimu-
lated for 8 h with 10 
 
m
 
g/ml OKT3 plus 50 ng/ml PMA or with 10
 
m
 
g/ml OKT3 alone. The cells were then lysed in 300 
 
m
 
l of
PicaGene ReporterLysis Buffer (Toyo Ink) and assayed for luci-
ferase and 
 
b
 
-galactosidase activities as described previously (25).
 
Results and Discussion
 
We previously reported a signal transducing adaptor
molecule, STAM, which is associated with Janus kinase
(Jak)2 and Jak3 and is involved in signal transduction medi- 
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ated by IL-2 and GM-CSF (26). We have also recently
cloned a cDNA clone encoding a novel molecule, named
AMSH, which binds to STAM (our unpublished results).
To address the functional significance of AMSH, we at-
tempted to identify molecules associated with AMSH using
the yeast two-hybrid assay system. One full-length cDNA
clone was isolated from a human PHA-PBL cDNA library.
The cDNA clone encodes a molecule homologous to
Grb2, named Grf40 (for Grb2 family member of 40 kD).
The nucleotide sequence of the Grf40 gene has been de-
posited with GenBank, and is available from EMBL/Gen-
Bank/DDBJ under accession no. AF042380. The deduced
amino acid sequence of Grf40 consists of 330 amino acid
residues. The schematic structure of Grf40 was compared
with Grb2 (7) and Grap, another Grb2 family member (27,
28). The NH
 
2
 
- and COOH-terminal SH3 domains and an
intermediate SH2 domain of Grf40 are highly homologous
to those of Grb2 and Grap, while a unique insert region
(amino acid position Arg
 
156
 
–Arg
 
277
 
) containing proline/
glutamine-rich sequences was seen in Grf40 but not Grb2
and Grap (Fig. 1 A). These results indicate that Grf40 is a
new member of the Grb2 family.
Various human cell lines were examined for expression
of Grf40 by immunoblotting with anti-Grf40 Ab. Two T
cell lines, MOLT-4 and Jurkat, were strongly positive for
expression of the 40-kD Grf40, and two B cell lines, Daudi
and Raji, were weakly positive, but the other cell lines, in-
cluding a B cell line (Ramos), myeloid cell lines (THP-1,
TF-1, and Eol-3), and the nonhematopoietic cell lines
(HeLa and WI-26) were all negative for this expression
(Fig. 1 B). In contrast to Grf40, appreciable expression of
Grb2 was seen in all the cell lines (Fig. 1 B). Northern blot
Figure 1. Schematic structure and expression of Grf40. (A) The schematic structure of Grf40 was compared with Grb2 and Grap. The percentages of
amino acid identity of the SH3 and SH2 domains of Grf40 with Grb2 and Grap were indicated in terms of their SH3 and SH2 domains. (B) 107 cells of
a variety of human cell lines were immunoprecipitated (IP) and immunoblotted (IB) with anti-Grf40, anti-Grb2, or preimmune (control [Cont]) serum.
(C) Northern blot analyses were performed with the various human tissues indicated. The blots were first hybridized with the Grf40 probe, then rehy-
bridized with b-actin probe. 
1386
 
Grf40 Involved in T Cell Signaling
 
analyses on various human cell lines and tissues showed two
Grf40-specific transcripts at 3.5 and 1.5 kb in Jurkat,
MOLT-4, three myeloid cell lines (KU812, K562, and
M-TAT) and PHA-PBL (data not shown), and in human
immunotissues such as thymus, spleen, small intestine, and
PBL, whereas marginal levels of the transcripts were detected
in other tissues, including prostate, testis, ovary, colon, heart,
brain, placenta, lung, liver, skeletal muscle, kidney, and pan-
creas (Fig. 1 C). These results suggest that Grf40, unlike
Grb2, is predominantly expressed in immunotissues and
hematopoietic cells, particularly T cells.
Since Grb2 has been shown to bind to SLP-76 and LAT,
which are 76- and 36/38-kD tyrosine-phosphorylated pro-
teins essential for TCR-mediated signaling, respectively
(10, 11, 18), we asked ourselves whether or not Grf40 is
also associated with SLP-76 and LAT. We detected 76- and
36/38-kD tyrosine-phosphorylated proteins that coimmuno-
precipitated with Grf40 in Jurkat cells after stimulation by
TCR cross-linking with OKT3 (Fig. 2 A). We then con-
firmed that the 76- and 36/38-kD tyrosine-phosphorylated
proteins were SLP-76 and LAT, respectively, by stimulat-
ing Jurkat cells with OKT3. Their lysates were immuno-
precipitated with anti-Grf40 Ab, and the immunoprecipitates
were then immunoblotted with anti-LAT, anti–SLP-76, or
anti-Grf40 Ab. Grf40 precipitated SLP-76 irrespective of
TCR stimulation, but precipitated LAT only after TCR
stimulation (Fig. 2 B). These results indicate the association
of Grf40 with SLP-76 and LAT in Jurkat cells. To deter-
mine the association site of Grf40 for SLP-76, we carried
out further coimmunoprecipitation assays between the var-
ious deletion mutants of Grf40 and SLP-76. COS7 cells
were transiently transfected with Myc-tagged wild-type
Grf40 and four Grf40 mutants deleted of the NH
 
2
 
-terminal
SH3 domain (Grf40-dSH3N), the COOH-terminal SH3
domain (Grf40-dSH3C), both the NH
 
2
 
- and COOH-termi-
nal SH3 domains (Grf40-dSH3NC), or the SH2 domain
Figure 2. Coimmunoprecipitation of
SLP-76 and LAT with Grf40 in Jurkat cells.
Jurkat cells were stimulated with (1) or
without (2) OKT3 for 3 min, and their ly-
sates were immunoprecipitated (IP) with
anti-Grf40 or preimmune (control) serum.
The immunoprecipitates were separated by
SDS-PAGE and then immunoblotted (IB)
with antiphosphotyrosine mAbs (A), and
with anti–SLP-76 antiserum or anti-LAT
Ab (B). COS7 cells were transiently trans-
fected with 10 mg expression plasmids for
Myc-tagged wild-type Grf40 (wild) or four
Myc-tagged Grf40 mutants (dSH3C, dSH2,
dSH3N, and dSH3NC), together with 10
mg expression plasmids for SLP-76 by elec-
troporation, and then incubated for 48 h.
Their lysates were immunoprecipitated with
anti–SLP-76 or preimmune (control) se-
rum, and then immunoblotted with anti-
Myc mAb or anti–SLP-76 antiserum (C).
COS7 cells were transiently transfected with
10 mg expression plasmids for Flag-tagged
wild-type SLP-76 (wild), four Flag-tagged
SLP-76 mutants (157-533, 217-533, 241-
533, and 281-533), or an empty vector
(control), together with 10 mg expression
plasmids for Myc-tagged Grf40 by elec-
troporation, and then incubated for 48 h.
Their lysates were immunoprecipitated with
anti-Flag mAb, and then immunoblotted
with anti-Myc or anti-Flag mAb (D). 
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(Grf40-dSH2). The transfected COS7 cells were immuno-
precipitated with anti–SLP-76 Ab or anti-Myc mAb, and
then immunoblotted with anti-Myc mAb or anti–SLP-76
Ab. Wild-type Grf40 and the Grf40-dSH2 and Grf40-dSH3N
mutants were coimmunoprecipitated with SLP-76, but the
Grf40-dSH3C and Grf40-dSH3NC mutants were not tested
(Fig. 2 C). Conversely, SLP-76 was coimmunoprecipitated
with Grf40-dSH2, Grf40-dSH3N, and wild-type Grf40,
but not with Grf40-dSH3C and Grf40-dSH3NC mutants
(data not shown). These results indicate that the COOH-
terminal SH3 domain of Grf40 is an association site for
SLP-76. We next determined the association site of SLP-76
for Grf40 by using various SLP-76 mutants. Flag-tagged
wild-type and four mutants of SLP-76 were introduced
into COS7 cells together with Myc-tagged Grf40, and then
immunoprecipitated and immunoblotted with anti-Flag
and anti-Myc Abs. Myc-tagged Grf40 was coimmunopre-
cipitated with the SLP-76 mutants consisting of and con-
taining the amino acid position Glu
 
217
 
–Pro
 
533
 
, but not with
the SLP-76 mutant consisting of the amino acid position
Pro
 
241
 
–Pro
 
533
 
. These results indicate that the Grf40 binding
site is located in the amino acid position Glu
 
217
 
–Lys
 
240
 
 of
SLP-76 (Fig. 2 D). This Grf40 binding site of SLP-76
almost overlaps the amino acid position Asn
 
224
 
–Asp
 
244
 
,
which has been shown to be the Grb2 binding site (15).
On the other hand, the binding site of Grb2 for LAT has
been shown to be the SH2 domain of Grb2, which is
thought to bind to the phosphorylated tyrosine residue
(18). Together with this notion, we showed that LAT is ty-
rosine phosphorylated and subsequently coimmunoprecipi-
tated with Grf40 after TCR stimulation, suggesting that the
SH2 domain of Grf40 is possibly the binding site for LAT.
Since the COOH-terminal SH3 domain of Grb2 has
 
been shown to be the binding site for SLP-76 (10, 11), we
examined the competitive binding ability between Grf40
and Grb2 to SLP-76. COS7 cells were transiently trans-
fected with 2.5-
 
m
 
g plasmids of Myc-tagged Grf40 and
Myc-tagged Grb2 in association with different doses (0–1.0
 
m
 
g) of Flag-tagged SLP-76 plasmid. Their lysates were immu-
noprecipitated with anti-Flag mAb and then immuno-
blotted with anti-Myc polyclonal Ab. Coimmunoprecipita-
tion of Myc-tagged Grf40 with SLP-76 gradually decreased
upon reducing the SLP-76 plasmid dose to 0.05 
 
m
 
g,
whereas the Myc-tagged Grb2 coimmunoprecipitation with
SLP-76 was detectable only at a 1.0-
 
mg dose of SLP-76
plasmid (Fig. 3 A). Expression levels of the plasmids intro-
duced were quantified by immunoblotting, confirming that
there was no significant difference in the amounts between
Myc-tagged Grf40 and Myc-tagged Grb2 (Fig. 3 A). These
results suggest the possibility that Grf40 associated much
stronger with SLP-76 than did Grb2. To confirm this fur-
ther, COS7 cells were transiently transfected with low
doses of SLP-76 plasmid (0.2 mg) and Myc-Grf40 plasmid
(2.5 mg) together with various doses (0–10 mg) of Myc-
tagged Grb2 plasmid. Their lysates were immunoprecipi-
tated with anti-Flag mAb and then immunoblotted with
anti-Myc polyclonal Ab. Even when up to 10-mg plasmid
doses of Myc-tagged Grb2 were cotransfected, coimmuno-
precipitation of Myc-tagged Grf40 with SLP-76 was still
unchanged (Fig. 3 B). Furthermore, although the increased
expression of Myc-tagged Grb2 was dependent on its plas-
mid dose, which was considerably higher than that of Grf40
at a 10-mg plasmid dose of Myc-tagged Grb2, Myc-tagged
Grb2 was not coimmunoprecipitated with SLP-76 (Fig.
3 B). These results indicate that Grf40 competes with Grb2
in its binding to SLP-76, and the binding affinity of Grf40 to
Figure 3. Competitive binding ability of
Grf40 and Grb2 to SLP-76. COS7 cells were
transiently transfected with the indicated doses
of pFlagSLP (SLP-76), 2.5 mg of pMycGrf40
(Grf40), and 2.5 mg of pMycGrb2 (Grb2) (A),
or 0.2 mg of pFlagSLP, 2.5 mg of pMycGrf40,
and the indicated doses of pMycGrb2 (B).
The cells were incubated for 48 h, and their
lysates were immunoprecipitated (IP) with
anti-Flag mAb and then immunoblotted (IB)
with anti-Myc polyclonal Ab or anti-Flag
mAb (top and middle). The expression levels
of Myc-tagged Grf40 and Myc-tagged Grb2
were quantified by immunoblotting with anti-
Myc mAb (bottom).1388 Grf40 Involved in T Cell Signaling
SLP-76 is apparently higher than that of Grb2. Since the
SLP-76 mutant deleted of the Grb2 binding site, which
overlaps the Grf40 binding site, failed to increase IL-2 pro-
moter activity upon TCR stimulation (15, 16), it is possible
that not only Grb2 but also Grf40 plays a critical role in the
SLP-76–dependent increase in IL-2 promoter activity.
To address the functional significance of Grf40 in TCR-
mediated signaling, we performed luciferase assays with re-
porter genes containing the IL-2 promoter and the NF-AT
binding domain. Overexpression of wild-type Grf40 did
not lead to either basal or TCR-mediated activation of the
IL-2 promoter and NF-AT (data not shown). Since Grf40
interacts with SLP-76 in Jurkat cells, and overexpression of
SLP-76 is known to augment TCR-mediated stimulation
of the IL-2 promoter and NF-AT activity (15, 16), we used
Jurkat cells transiently transfected with SLP-76 to examine
the effect of Grf40 in TCR-mediated signaling. Transfec-
tions of wild-type Grf40 and Grf40-dSH3N mutant into
Jurkat cells overexpressing SLP-76 led to significant increases
in IL-2 promoter activity upon stimulation with OKT3 plus
PMA, whereas transfection of Grf40-dSH2 mutant induced
a marked inhibition of IL-2 promoter activity compared
with transfection of an empty vector (Fig. 4 A). These results
indicate that Grf40-dSH2 mutant has a dominant-negative
effect in TCR stimulation, suggesting that the SH2 domain
of Grf40 interacts with an essential molecule for TCR-medi-
ated signaling, which is possibly LAT (18). Similar results
were obtained in NF-AT luciferase assays with Jurkat cells
stimulated with OKT3 (Fig. 4 B). Furthermore, the Grf40
mutants (Grf40-dSH3C and Grf40-dSH3NC) deleted of the
COOH-terminal SH3 domain, which is the binding site
for SLP-76, also lost their ability to increase IL-2 promoter
activity (Fig. 4 A), suggesting that a Grf40–SLP-76 complex
formation is required for SLP-76–dependent TCR stimula-
tion. These results indicate that Grf40 is involved in signaling
the stimulation of the IL-2 promoter and NF-AT activities
mediated by OKT3 and PMA.
Since Grb2 has also been considered to be involved in
the modulation of TCR-mediated signal transduction (9),
we compared the functional significance of Grf40 and
Grb2 in TCR-mediated stimulation of IL-2 promoter ac-
tivity. Jurkat cells overexpressing SLP-76 were transfected
with the wild-types and SH2 deletion mutants of Grf40
and Grb2, in association with an IL-2 promoter–driven lu-
ciferase construct. They were stimulated with OKT3 plus
PMA, and assayed for luciferase activity. An appreciable en-
hancement of IL-2 promoter activity was seen with wild-
type Grf40, but scarcely with wild-type Grb2, whereas
Grf40-dSH2 mutant showed a marked dominant-negative
effect in the IL-2 luciferase assay compared with Grb2-dSH2
mutant (Fig. 5 A). The plasmid dose dependency in the IL-2
luciferase assay was compared between the Grf40-dSH2 and
Grb2-dSH2 mutants. The suppressive effects on the lu-
ciferase activities were significantly stronger in Grf40-dSH2
mutant than Grb2-dSH2 mutant at various plasmid doses
(Fig. 5 B). These results indicate that Grf40 is involved in
TCR-mediated signaling more effectively than Grb2. This
conclusion is in accordance with the observation of greater
binding affinity of Grf40 to SLP-76 compared with Grb2.
This study showed a critical involvement of Grf40 in the
SLP-76–dependent signaling mediated by the TCR. One
might consider the possibility that Grf40 mutants exert
their effects in TCR-mediated signaling by altering expres-
sion levels of SLP-76. However, this possibility is negligible
because the expression of pCX-SLP76 was confirmed to be
unaffected by transient expression of Grf40, Grb2, and their
mutants in COS7 cells (data not shown). Hence, the inter-
action of Grf40 with SLP-76 and LAT is thought to be
critical for TCR-mediated signaling.
The NH2-terminal SH3 domain of Grb2 is known to be
a binding site for Sos, a Ras guanine nucleotide exchange
factor, which has been considered to be involved in Ras
activation upon TCR stimulation (9). We confirmed the
association of Grb2 with Sos in Jurkat cells; however, a
complex formation between Grf40 and Sos was undetect-
able in these cells (data not shown). Therefore, we suspect
Figure 4. Effects of Grf40 mutants on TCR-mediated activation of IL-2 promoter and NF-AT activities. Jurkat cells were transfected with 10 mg of IL-2-
Luc (A) or 10 mg of NF-AT-Luc (B), along with 10 mg of SLP-76 and 10 mg of an empty vector (vector), Myc-tagged wild-type Grf40 (wild), or various
Grf40 mutants (dSH3N, dSH3C, dSH3NC, and dSH2). The cells were left unstimulated (white bars) or were stimulated (black bars) with 10 mg/ml OKT3
plus 50 ng/ml PMA, and assayed for luciferase activity. Results are shown as fold induction of luciferase activity compared with the activity in unstimulated
cells transfected with the empty vector (z5,000 relative light units [RLU]). These results are representative of three comparable experiments.1389 Asada et al.
that Grf40 does not direct the Ras activation signaling me-
diated by the TCR. However, Grf40 contributes to TCR-
mediated activation of the IL-2 promoter and NF-AT
more effectively than Grb2, suggesting the critical involve-
ment of Grf40 in TCR-mediated signaling. In this context,
it is of interest that SLP-76 associated with Grf40 also binds
to Vav, a Rac/Rho guanine nucleotide exchange factor, and
that the interaction between SLP-76 and Vav has been shown
to participate in IL-2 gene activation upon TCR stimulation
(17). These observations provide a model pathway in which
activated ZAP-70 tyrosine kinase after TCR ligation phos-
phorylates LAT (18), which then binds to the preformed
Grf40–SLP-76 complex and recruits it to ZAP-70 (29), which
further phosphorylates SLP-76 to be associated with Vav,
leading to the downstream signaling of the TCR.
Northern blot and immunoblot analyses revealed that
Grf40 is expressed predominantly in immunotissues and he-
matopoietic cells, particularly T cells, in contrast to Grb2.
Such restricted distribution of Grf40 may reflect the more ef-
ficient involvement of Grf40 in TCR-mediated signaling
compared with Grb2. Although Grap has also been shown
to be specific for hematopoietic and lymphocytic cells (28),
the functional significance of Grap is still unknown.
The genome sequence of GRB2L has been registered
in GenBank/EMBL/DDBJ (under accession no. Z82206),
which contains the entire sequence of Grf40. Since GRB2L
has been mapped to human chromosome 22q12, Grf40 is
thought to have the same chromosomal location. Further-
more, cDNA clones identical to Grf40 were reported as
Grap2 (30), and human Gads (31) and their mouse homo-
logues, named Mona (32) and mouse Gads (33), were also re-
ported after the submission of this paper. Although the report
regarding human Gads showed similar results as our study,
they did not show any comparative study between Gads and
Grb2. We here show evidence suggesting that Grf40 plays a
more critical role in the TCR-mediated signaling than Grb2.
We thank Dr. H. Onodera for providing Myc-Tag-pcDNA3.1(1), and Drs. S. Moffatt and L.C. Ndhlovu
for critical reading of the manuscript. 
This work was supported in part by Core Research for Evolutional Science and Technology (CREST) of
the Japan Science and Technology Corporation; by a grant-in-aid for scientific research on priority areas
from the Ministry of Education, Science, Sport, and Culture of Japan; and by a grant from special coordina-
tion funds of the Science and Technology Agency of Japan.
Address correspondence to Kazuo Sugamura, Department of Microbiology and Immunology, Tohoku Uni-
versity School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan. Phone: 81-22-717-8096;
Fax: 81-22-717-8097; E-mail: sugamura@mail.cc.tohoku.ac.jp
Received for publication 19 October 1998 and in revised form 1 March 1999.
Figure 5. Comparison of blocking effects between Grf40-dSH2 and Grb2-dSH2 on TCR-mediated stimulation of IL-2 promoter activity. (A) Jurkat cells
were transfected with 10 mg of IL-2-Luc along with 10 mg of SLP-76 and 10 mg of an empty vector (vector), Myc-tagged Grf40 wild-type, Grf40-dSH2,
Grb2 wild-type, or Grb2-dSH2. The cells were left unstimulated (white bars) or were stimulated (black bars) with OKT3 plus PMA. (B) Jurkat cells were
transfected with 10 mg of IL-2-Luc along with 10 mg of SLP-76 and the indicated doses of Grf40-dSH2 (squares) or Grb2-dSH2 (circles). The cells were left
unstimulated (open symbols) or were stimulated (filled symbols) with OKT3 plus PMA, and assayed for luciferase activity. Luciferase activity was indicated as
average fold induction 6 SE from three independent experiments compared with unstimulated cells transfected with the empty vector (z5,000 RLU).
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